Binghamton researcher awarded $2.75M antibody-drug-conjugate grant
- Posted on April 23, 2026
- By Google News
- 0 Views
- 1 min read
Binghamton researcher awarded $2.75M antibody-drug-conjugate grant

Backed by a NIH grant, Binghamton researcher L. Nathan Tumey is advancing antibody-drug-conjugate technology for the treatment of cancer and immunological disorders, exploring flexible approaches for cell-specific drug delivery.